INHIBITION OF DEGRANULATION OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY COMPLEMENT-FACTOR-D

被引:31
作者
BALKE, N
HOLTKAMP, U
HORL, WH
TSCHESCHE, H
机构
[1] UNIV BIELEFELD, FAC CHEM, DEPT BIOCHEM, D-33501 BIELEFELD, GERMANY
[2] ALLGEMEINES KRANKENHAUS WIEN, NEPHROL & DIALYSIS ABT, VIENNA, AUSTRIA
来源
FEBS LETTERS | 1995年 / 371卷 / 03期
关键词
COMPLEMENT FACTOR D; ADIPSIN; RENAL FAILURE; NEUTROPHIL; DEGRANULATION;
D O I
10.1016/0014-5793(95)00926-Z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A degranulation inhibiting protein could be isolated from human plasma ultrafiltrate by a three-step purification method including ion-exchange chromatography gelfiltration and affinity-chromatography. The protein was identified as complement factor D by means of sequence analysis, Its degranulation inhibiting activity was determined with regard to its effect on the FNLPNTL-induced lactoferrin secretion of human polymorphonuclear leukocytes. Complement factor D caused a dose-dependent decrease of the FNLPNTL-stimulated lactoferrin degranulation down to 34% of stimulated controls.
引用
收藏
页码:300 / 302
页数:3
相关论文
共 22 条
[1]  
BERGMANN U, 1989, J CLIN CHEM CLIN BIO, V27, P351
[2]   AFFINITY CHROMATOGRAPHY OF PHOSPHOFRUCTOKINASE USING CIBACRON BLUE F3G-A [J].
BOHME, HJ ;
HOFMANN, E ;
SCHULZ, J ;
KOPPERSCHLAGER, G .
JOURNAL OF CHROMATOGRAPHY, 1972, 69 (01) :209-+
[3]   PURIFICATION OF HUMAN-COMPLEMENT FACTOR-D FROM THE PERITONEAL-FLUID OF PATIENTS ON CHRONIC AMBULATORY PERITONEAL-DIALYSIS [J].
CATANA, E ;
SCHIFFERLI, JA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 138 (02) :265-271
[4]   A SIMPLIFICATION OF HEUKESHOVEN AND DERNICKS SILVER STAINING OF PROTEINS [J].
DAMERVAL, C ;
LEGUILLOUX, M ;
BLAISONNEAU, J ;
DEVIENNE, D .
ELECTROPHORESIS, 1987, 8 (03) :158-159
[5]   HUMAN FACTOR-D OF THE ALTERNATIVE COMPLEMENT PATHWAY - PHYSICOCHEMICAL CHARACTERISTICS AND N-TERMINAL AMINO-ACID SEQUENCE [J].
DAVIS, AE ;
ZALUT, C ;
ROSEN, FS ;
ALPER, CA .
BIOCHEMISTRY, 1979, 18 (23) :5082-5087
[6]  
DEPPISCH R, 1994, KIDNEY INT, V45, pS77
[7]  
HORI WH, 1990, P NATL ACAD SCI USA, V87, P5480
[8]   DECREASED ACTIVITY OF COMPLEMENT-MEDIATED IMMUNE-COMPLEX CLEARANCE IN HEMODIALYSIS-PATIENTS [J].
INAGI, R ;
MIYATA, T ;
HONG, KS ;
PRAMOONJAGO, P ;
MAEDA, K ;
INOUE, K .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 68 (03) :333-339
[9]   MECHANISM OF ACTION OF FACTOR-D OF ALTERNATIVE COMPLEMENT PATHWAY [J].
LESAVRE, PH ;
MULLEREBERHARD, HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (06) :1498-1509
[10]   FLUID-PHASE ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY EXCESS FACTOR-D IN REGULARLY DIALYZED PATIENTS [J].
MIYATA, T ;
INAGI, R ;
HONG, K ;
IIDA, Y ;
ODA, O ;
KINOSHITA, T ;
INOUE, K ;
MIYAMA, A ;
MAEDA, K .
NEPHRON, 1992, 60 (02) :144-149